Weight Loss Drug Marketing and First Nations People: Focus on Health Awareness or Company Profit?

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have seen increased off-label prescriptions and supply shortages, raising equity concerns for First Nations peoples.

• Pharmaceutical marketing strategies often target First Nations women through disease-awareness campaigns and sponsored events.
• These marketing efforts may shape perceptions of body image and influence prescribing practices.
• Systemic conditions that contribute to health inequity among First Nations peoples are not adequately addressed by these marketing approaches.
• There is a call for clinicians and policymakers to make decisions that are free from commercial influence.

Simplified